Medicine and Healthcare | Media Room of AmplifyBio

Media Room RSS

Press Contact

Madeleine Moench

madeleine@newswire.com

About AmplifyBio

AmplifyBio is an Ohio-based preclinical CRO and CDMO operating a laboratory and vivarium site conducting toxicology, safety, and efficacy with enhanced analytic capabilities and a cGMP manufacturing facility with multi-modality manufacturing suites.

Learn More »

Address

AmplifyBio

1425 NE Plain City-Georgesville Rd

West Jefferson, OH 43162

United States

+19047385897

Category: Medicine and Healthcare

Press Release Jan 30, 2025

AmplifyBio Drives Key Conversations at Phacilitate's Advanced Therapy Week in Dallas

Press Release Oct 31, 2023

AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share Capabilities that Enhance the Safety and Scalability of Lentiviral-based Gene Therapeutics

Press Release Apr 3, 2023

Dispatch Media Group Names AmplifyBio a Winner of The Columbus Top Workplaces 2023 Award

Press Release Jul 12, 2022

AmplifyBio Celebrates One Year Since Launch With an Expansion of Capabilities and Capacity and a New Site

A preclinical CRO built for the future on a foundation of experience: amplify-bio.com

Press Release Jul 30, 2024

AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities

Press Release May 25, 2023

AmplifyBio Celebrates 2 Years of Innovative Solutions, Preclinical Drug Development and Safety

Press Release Mar 16, 2023

AmplifyBio Emerges as a Leader in Cell Therapy Characterization, Filling a Gap in Pre-Clinical Development

AmplifyBio builds on the T-cell immunology expertise of its South San Francisco-based team, adding technology platforms and capabilities in single-cell analysis and product assessment in the context of a tumor microenvironment.

Press Release Nov 7, 2023

AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity

Press Release May 15, 2023

AmplifyBio Adds Manufacturing Capabilities to Expand Service Portfolio

AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies.

Press Release Jan 12, 2023

AmplifyBio Secures $50M in Debt Financing With Hercules Capital to Accelerate Business Plan

AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics

Press Releases	Instant	Daily	Never
News	Instant	Daily	Never
Event	Instant	Daily	Never
Blog		Daily	Never
Facebook		Daily	Never
Twitter		Daily	Never